Talis Biomedical Corp
TLISDelisted Sep 20, 2024- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001584751
Talis Biomedical Corp was delisted on Sep 20, 2024; its insiders filed their last Form 4 on Sep 9, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $6.84M in total; Greenlight Capital was the only superinvestor holding it.
Q3 2021 vs. Q2 2021
How the institutions holding Talis Biomedical Corp changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 43 | 1 | 38 | −4 |
| Shares | 19.6M | 33.8K | 19.1M | −494.1K (−2.5%) |
| Value | $184.0M | $373.0K | $119.2M | −$64.4M (−35.1%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Talis Biomedical Corp at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| PDT Partners, LLC | 30,109 | $188.0K | 0.01% |
| Citadel Advisors LLC | 26,146 | $163.0K | 0.00% |
| Qube Research & Technologies Ltd | 23,298 | $146.0K | 0.00% |
| Personal Cfo Solutions, LLC | 17,000 | $106.0K | 0.02% |
| Prelude Capital Management, LLC | 12,337 | $77.0K | 0.00% |
| Chicago Partners Investment Group LLC | 10,000 | $54.0K | 0.00% |
| Group One Trading, L.P. | 825 | $5.00K | 0.00% |
Sold out (11)
Institutions that held Talis Biomedical Corp at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Redmile Group, LLC | 363,849 | $4.01M |
| Alyeska Investment Group, L.P. | 100,000 | $1.10M |
| Jacobs Levy Equity Management, Inc | 29,636 | $327.0K |
| Cubist Systematic Strategies, LLC | 22,920 | $253.0K |
| Wells Fargo & Company | 19,557 | $216.0K |
| Legato Capital Management LLC | 18,585 | $205.0K |
| Federated Hermes, Inc. | 15,000 | $165.0K |
| Millennium Management LLC | 14,219 | $157.0K |
| Marshall Wace, LLP | 11,326 | $125.0K |
| Norges Bank | 10,000 | $110.0K |
| UBS Group AG | 541 | $6.00K |
Not filed for Q3 2021 yet (1)
Institutions that held Talis Biomedical Corp at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pictet Asset Management Ltd | 33,845 | $373.0K |